Successful Collaboration: Solution Concepts for Sensitive Substances
Specialty glass manufacturer SCHOTT AG and pharma label expert Schreiner MediPharm have been engaged in an intensive partnership for several years. Its objective is the development of solution concepts enabling a wider use of polymer syringes in the pharmaceutical sector.
Effectively Shielded API: Light Protection Labels for Micafungin
UV light lifts our spirit, enhances our immune response, and helps us produce vitamin D—a totally positive effect for the human body. However, UV radiation may have a damaging impact on some active pharmaceutical ingredients (APIs) because they may lose
Cosmeceuticals: Syringe Labels for Beauty
Beauty is a subject that has always played a major role in the world’s diverse cultures over the centuries. Today, the question of personal beauty has greater relevance than ever before and is reinforced by the power of pictures and
Acute Care: Every Second Counts!
Wailing sirens, flashing blue lights, and a medevac helicopter hovering above the scene: In the event of an accident involving potential loss of lives, the victims require immediate medical attention. For first responders, paramedics, and emergency room physicians, this means
Full Service for Cap-Lock: Partnership with Plas-Tech Engineering
In the fall of 2019, Schreiner MediPharm launched Cap-Lock, an innovative first-opening indication for prefilled syringes, followed by a product evolution less than a year later: The label now featured an RFID inlay integrated at the level of the cap
Future Healthcare: Digitalization of Health
Schreiner Group’s first contact with a pharmaceutical corporation took place in 1988. It resulted in the development of Pharma-Tac, a hanger label for infusion bottles and a world first. From then on, the company specialized in solutions for the pharmaceutical
CSL Behring Clinical Trial: Securely Blinded with Flexi-Cap
Since the spring of 2020 a novel virus has taken hold of the world: the coronavirus SARS-CoV-2. Research scientists are working at full stretch on the development of a vaccine. But pharmaceuticals—whether vaccines or other drugs—have a long way to